Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease [Yahoo! Finance]
Lindsay Launches the Road Runner™: The Next Generation of Truck-Mounted Attenuators
Lindsay Launches AlphaGuard™ Channelizing Device: A Solid Solution for Modern Safety Challenges
Lindsay (NYSE:LNN) was given a new $128.00 price target on by analysts at Stifel Nicolaus.
Lindsay declares $0.37 dividend [Seeking Alpha]